Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.96
+0.08 (1.16%)
At close: Sep 11, 2025, 4:00 PM EDT
6.88
-0.08 (-1.15%)
After-hours: Sep 11, 2025, 7:29 PM EDT

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
145155--
Enterprise Value
138142--
Last Close Price
6.967.96--
PB Ratio
-1492.25--
P/TBV Ratio
-1492.25--
Quick Ratio
0.710.980.434.71
Current Ratio
0.731.050.434.71
Return on Equity (ROE)
---442.40%-
Return on Assets (ROA)
-348.95%-255.41%-132.96%-
Return on Capital (ROIC)
---279.06%-
Earnings Yield
-17.07%-17.55%--
Buyback Yield / Dilution
-1044.18%-483.48%-18.54%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q